Literature DB >> 14709715

Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999.

Dawn K Smith1, Lytt I Gardner, Ruby Phelps, Merle E Hamburger, Charles Carpenter, Robert S Klein, Ann Rompalo, Paula Schuman, Scott D Holmberg.   

Abstract

HIV/AIDS-associated and non-HIV/AIDS-associated death rates and causes of death between 1993 and 1999 were examined in 885 HIV-infected women and 425 uninfected women of the HIV Epidemiology Research Study cohort. Causes of death were determined by review of death certificates and the National Death Index. Adjusted hazard ratios were calculated for mortality risk factors. In the 885 HIV-infected women and 425 uninfected women, 234 deaths and 8 deaths, respectively, occurred by December 31, 1999. All-cause death rates in the HIV-infected women were unchanged between the pre-HAART (1993-1996) and HAART eras (1997-1999)-5.1 versus 5.4 deaths per 100 person-years (py). AIDS as a cause of death decreased from 58% of all deaths in 1996 to 19% in 1999, while HAART use increased to 42% by the end of 1999. In spite of the modest proportion ever using HAART, HIV-related mortality rates did decline, particularly in women with CD4+ cell counts less than 200/mm(3). Drug-related factors were prominent: for the 129 non-AIDS-defining deaths, hepatitis C positivity (relative hazard [RH] 2.6, P <.001) and injection drug use (RH 1.7, P = 0.02) were strong predictors of mortality, but were not significant in the Cox model for 105 AIDS-defining deaths (RH 0.9, P >.30 and RH 0.7, P >.30, respectively. The regression analysis findings, along with the high percentage of non-AIDS deaths attributable to illicit drug use, suggest that high levels of drug use in this population offset improvements in mortality from declining numbers of deaths due to AIDS.

Entities:  

Mesh:

Year:  2003        PMID: 14709715      PMCID: PMC3456216          DOI: 10.1093/jurban/jtg074

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  37 in total

1.  Mortality due to chronic viral liver disease among patients infected with human immunodeficiency virus.

Authors:  V Soriano; L Martín-Carbonero; J García-Samaniego; M Puoti
Journal:  Clin Infect Dis       Date:  2001-11-15       Impact factor: 9.079

2.  Multicenter evaluation of hepatitis C RNA levels among female injection drug users.

Authors:  D L Thomas; J D Rich; P Schuman; D K Smith; J A Astemborski; K R Nolt; R S Klein
Journal:  J Infect Dis       Date:  2001-02-21       Impact factor: 5.226

3.  Accuracy of death certification in two tertiary care military hospitals.

Authors:  S J Cina; D M Selby; B Clark
Journal:  Mil Med       Date:  1999-12       Impact factor: 1.437

4.  Association of provider and patient characteristics with HIV-infected women's antiretroviral therapy regimen.

Authors:  B J Turner; D Zhang; C Laine; R J Pomerantz; L Cosler; W W Hauck
Journal:  J Acquir Immune Defic Syndr       Date:  2001-05-01       Impact factor: 3.731

5.  Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995--1999.

Authors:  H Valdez; T K Chowdhry; R Asaad; I J Woolley; T Davis; R Davidson; N Beinker; B M Gripshover; R A Salata; G McComsey; S B Weissman; M M Lederman
Journal:  Clin Infect Dis       Date:  2000-04-17       Impact factor: 9.079

6.  Factors associated with errors in death certificate completion. A national study in Taiwan.

Authors:  T H Lu; W Y Shau; T P Shih; M C Lee; M C Chou; C K Lin
Journal:  J Clin Epidemiol       Date:  2001-03       Impact factor: 6.437

7.  Trends in causes of death in the Aquitaine cohort of HIV-infected patients, 1995-1997.

Authors:  S Vandentorren; P Mercié; C Marimoutou; D Neau; D Malvy; S Farbos; F Dabis
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

8.  Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus.

Authors:  A Duerr; B Kieke; D Warren; K Shah; R Burk; J F Peipert; P Schuman; R S Klein
Journal:  Am J Obstet Gynecol       Date:  2001-03       Impact factor: 8.661

9.  Methods to assess population effectiveness of therapies in human immunodeficiency virus incident and prevalent cohorts.

Authors:  P M Tarwater; J Mellors; M E Gore; J B Margolick; J Phair; R Detels; A Muñoz
Journal:  Am J Epidemiol       Date:  2001-10-01       Impact factor: 4.897

10.  Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection.

Authors:  I Bica; B McGovern; R Dhar; D Stone; K McGowan; R Scheib; D R Snydman
Journal:  Clin Infect Dis       Date:  2001-01-23       Impact factor: 9.079

View more
  12 in total

1.  HIV morbidity and mortality in Jamaica: analysis of national surveillance data, 1993--2005.

Authors:  Elena Losina; Peter Figueroa; Jacqueline Duncan; Nomita Divi; Lindsey L Wolf; Lisa R Hirschhorn; Minnette Robertson; Kevin Harvey; Sheldon Whorms; Kenneth A Freedberg; Yitades Gebre
Journal:  Int J Infect Dis       Date:  2007-08-13       Impact factor: 3.623

2.  AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatment.

Authors:  Kathleen Falster; Jun Yong Choi; Basil Donovan; Chris Duncombe; Brian Mulhall; David Sowden; Jialun Zhou; Matthew G Law
Journal:  AIDS       Date:  2009-11-13       Impact factor: 4.177

Review 3.  HIV, HCV, and Health-Related Harms Among Women Who Inject Drugs: Implications for Prevention and Treatment.

Authors:  Jenny Iversen; Kimberly Page; Annie Madden; Lisa Maher
Journal:  J Acquir Immune Defic Syndr       Date:  2015-06-01       Impact factor: 3.731

Review 4.  HIV infection and risk of overdose: a systematic review and meta-analysis.

Authors:  Traci C Green; Samuel K McGowan; Michael A Yokell; Enrique R Pouget; Josiah D Rich
Journal:  AIDS       Date:  2012-02-20       Impact factor: 4.177

5.  HIV/AIDS and Colorectal Cancer: A Review in the Era of Antiretrovirals.

Authors:  Ryan M Ford; Matthew M McMahon; Mohammad A Wehbi
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-04

6.  Black-White mortality from HIV in the United States before and after introduction of highly active antiretroviral therapy in 1996.

Authors:  Robert S Levine; Nathaniel C Briggs; Barbara S Kilbourne; William D King; Yvonne Fry-Johnson; Peter T Baltrus; Baqar A Husaini; George S Rust
Journal:  Am J Public Health       Date:  2007-08-29       Impact factor: 9.308

7.  Recent drug use, homelessness and increased short-term mortality in HIV-infected persons with alcohol problems.

Authors:  Alexander Y Walley; Debbie M Cheng; Howard Libman; David Nunes; C Robert Horsburgh; Richard Saitz; Jeffrey H Samet
Journal:  AIDS       Date:  2008-01-30       Impact factor: 4.177

8.  How do outcomes compare between women and men living with HIV in Australia? An observational study.

Authors:  Michelle L Giles; Marin C Zapata; Stephen T Wright; Kathy Petoumenos; Miriam Grotowski; Jennifer Broom; Matthew G Law; Catherine C O'Connor
Journal:  Sex Health       Date:  2016-04       Impact factor: 2.706

9.  Accommodating informative dropout and death: a joint modelling approach for longitudinal and semi-competing risks data.

Authors:  Qiuju Li; Li Su
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2017-01-30       Impact factor: 1.864

10.  Cocaine- and opiate-related fatal overdose in New York City, 1990-2000.

Authors:  Kyle T Bernstein; Angela Bucciarelli; Tinka Markham Piper; Charles Gross; Ken Tardiff; Sandro Galea
Journal:  BMC Public Health       Date:  2007-03-09       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.